Clinical Trials Sponsored by Alberta Diabetes Institute

Total 3217 results

Scripps Whittier Diabetes Institute

Recruiting

Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age (Dulce Digital)

Diabetes Type 2

United States
Scripps Whittier Diabetes Institute

Completed

Community Approach to Reduce the Risks of Diabetes After Gestational Diabetes Mellitus

Diabetes
University of Alberta
Alberta Innovates Health Solutions; Institute of Health Economics, Canada

Recruiting

Implementation of CRRT KPI Reports to Standardize and Improve the Quality of CRRT Delivery in Alberta "QUALITY CRRT" (QUALITY-CRRT)

Critical Illness | Acute Kidney Failure

Canada
University of Alberta
Canadian Institutes of Health Research (CIHR); Alberta Health services; Alberta... and other collaborators

Completed

CHANGE Cancer Alberta: A Primary Care Program for Cancer Prevention and Screening (CHANGECaAB)

Metabolic Syndrome | Risk Factors
University of Alberta
Canadian Institutes of Health Research (CIHR); Alberta Health services; Alberta... and other collaborators

Enrolling by invitation

BedMed-Frail: Does the Potential Benefit of Bedtime Antihypertensive Prescribing Extend to Frail Populations?

Hypertension | Dementia

Canada
Albert Einstein College of Medicine
Juvenile Diabetes Research Foundation; National Institutes of Health (NIH)

Completed

Reactive Oxygen Species in the Pathogenesis of Diabetic Complications

Type 1 Diabetes

United States
University of Alberta
Canadian Institutes of Health Research (CIHR); Alberta Health services

Not yet recruiting

UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events (UPTAKE-1)

Acute Kidney Injury
University of Alberta
Canadian Institutes of Health Research (CIHR); Alberta Health services

Recruiting

Fructose and Liver Diseases in Youth: Help Them FLY (FLY)

Non-alcoholic Fatty Liver Disease

Canada
Ottawa Hospital Research Institute
Alberta Cancer Foundation

Recruiting

Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial) (PATH)

Hematologic Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients

Metastatic Solid Malignancies | Locally Advanced Solid Malignancies

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Studying if Adding Night Compression to Standard Care Will Have Improved Control of Lymphedema in Breast Cancer Subjects (LYNC)

Breast Cancer | Lymphedema

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy

Prostate Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

Metabolism of Lipids in Advanced Cancer

Lung Neoplasms | Cachexia

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

The Feasibility of Physical Activity in Advanced Cancer Patients

Advanced Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer

Lung Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

Lymphoma | Lung Neoplasms | Colorectal Neoplasms | Brain Neoplasms | Thyroid Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Development of Magnetic Resonance (MR) Simulation for Treatment Planning

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy

Head and Neck Cancer
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma

-Breast Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy

Breast Cancer
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Quantifying Lung Tumor Movement Under Deep Inspiration Breath Holds

Lung Cancer

Canada
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease

Proteinuria | Chronic Renal Insufficiency

United States
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States

Diabetes | Malnutrition; Diabetes
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Controlling Hypertension in Diabetes- Feasibility Study (COACH-D)

Hypertension | Type 2 Diabetes | Hyperlipidemia

United States
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

Type 1 Diabetes

United States
AHS Cancer Control Alberta
Cross Cancer Institute

Not yet recruiting

Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions

Spinal Metastases

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Recruiting

Unilateral Neck Radiotherapy in Head and Neck Cancer

Head and Neck Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours (DCA)

Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

Sarcoma | Kidney Neoplasms | Testicular Neoplasms | Multiple Myeloma | Ovarian Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer

Prostatic Neoplasms | Neoplasm Metastasis | Palliative Care

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea

Metastatic Colorectal Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer

Prostate Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer (IMRT)

Locally Advanced Cervical Cancer | Integrated MRI Based RT as Standard of Care
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma

Sarcoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation

Prostate Cancer | Osteoporosis

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation

Prostatic Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin

Colorectal Cancer | Metastasis | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Cone Beam CT Scanning in Lung and Bladder Cancer.

Bladder Carcinoma | Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer

Carcinoma, Small Cell

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide

Glioma | Glioblastoma

Canada
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

T1DTechCHW: Enhancing the Community Health Worker Model to Promote Diabetes Technology Use in Young Adults From Underrepresented Minority Groups (T1DTechCHW)

Diabetes Mellitus | Diabetes | Type 1 Diabetes | Young Adult

United States
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

2-A-Day Study: Twice a Day Meals Study.

PreDiabetes

United States
National Institute of Diabetes and Digestive and...
Albert Einstein College of Medicine

Completed

Family Weight Management Study

Obesity | Diabetes

United States
Albert B. Sabin Vaccine Institute

Completed

Prevalence of Hookworm Infection and Community Preparedness for Hookworm Vaccine Trials in Endemic Areas of Brazil

Hookworm Infection

Brazil

Clinical Trials Sponsored by Alberta Diabetes Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations